Brief: Anavex Life Sciences Reports Fiscal 2023 Third Quarter Financial Results
08/08/2023 13:25
Aug 8 (Reuters) - Anavex Life Sciences Corp AVXL.O :
* ANAVEX LIFE SCIENCES REPORTS FISCAL 2023 THIRD QUARTER
FINANCIAL
RESULTS
* CASH AND CASH EQUIVALENTS OF $154.8 MILLION AT JUNE 30,
2023
* QTRLY NET LOSS PER SHARE $0.14
* Q3 EARNINGS PER SHARE VIEW $-0.17 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3T6lX7
Further company coverage: AVXL.O
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board